Radiation therapy for primary central nervous system lymphoma

Main Article Content

Yuta Shibamoto (1*)

1 Department of Radiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
(*) Corresponding Author:
Yuta Shibamoto
yshiba@med.nagoya-cu.ac.jp

Abstract

Up until the late 1970s, radiation therapy played an important role in the treatment of primary central nervous system lymphoma (PCNSL) but more recently its role has changed due to the increased use of systemic chemotherapy. In this article, the current status of radiotherapy for PCNSL and optimal forms of radiotherapy, including the treatment volume and radiation dose, are discussed. Data from nationwide Japanese surveys of PCNSL patients treated with radiation therapy suggest that the prognosis of PCNSL patients improved during the 1990s, in part due to the use of high-dose methotrexate-containing chemotherapy. The prognosis of patients treated with radiation alone also improved. Radiotherapy still seems to play an important role in the attempt to cure this disease.

Downloads month by month

Downloads

Download data is not yet available.

Article Details

How to Cite
Shibamoto, Y. (2013). Radiation therapy for primary central nervous system lymphoma. Oncology Reviews, 7(1), e4. https://doi.org/10.4081/oncol.2013.e4